ORANGE COUNTY

ICN Seeks Merger OK: ICN Pharmaceuticals Inc. will urge shareholders at its annual meeting Tuesday to approve an intra-company merger that would consolidate three partially owned subsidiaries. To streamline operations and create a company with $500 million in sales, the Costa Mesa company wants shareholders of SPI Pharmaceuticals Inc., Viratek Inc. and ICN Biomedicals Inc. to accept one share of ICN stock for each share of their stock. The new company would retain the ICN Pharmaceuticals name, and Biomedicals would operate as a subsidiary.